InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,266.95
(
0.00%
)
US TECH 100
18,212.80
(
-0.25%
)
Dow Jones
38,441.54
(
0.00%
)
Brent Oil
82.57
(
-0.97%
)
Bitcoin
68,239.80
(
0.97%
)

Replies to post #301 on Revance Therapeutics Inc (RVNC)

Replies to #301 on Revance Therapeutics Inc (RVNC)

DewDiligence

11/30/17 6:30 PM

#302 RE: biotech_researcher #301

RVNC advances cervical-dystonia program to phase-3 (11/29/17 PR):

http://investors.revance.com/releasedetail.cfm?ReleaseID=1050212

A single global phase-3 program will be conducted to satisfy both the FDA and EMA.